Infection control

Devices & Diagnostics

mBio Diagnostics gets $3.2M to bring bedside testing for infectious diseases to developing countries

A portable, easy-to-use bedside device could make it easier for clinics in developing countries to test for HIV, hepatitis, syphilis and other infectious diseases. mBio Diagnostics Inc. just brought in $3.9 million to begin commercializing its first products overseas, according to co-founder and CEO Christopher Myatt. Those first products include a CD4 T-cell enumeration test, […]